BeiGene Ltd.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 10K
- Market Cap
- $22.1B
- Website
- http://www.beigene.com
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- BeiGene
- Target Recruit Count
- 385
- Registration Number
- NCT02343120
- Locations
- 🇦🇺
St George Hospital, Sydney, New South Wales, Australia
🇦🇺Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
🇦🇺Peter MacCallum Cancer Centre, East Melbourne, Parkville, Victoria, Australia
© Copyright 2024. All Rights Reserved by MedPath